Lupin is currently trading at Rs. 563.95, up by 1.25 points or 0.22% from its previous closing of Rs. 562.70 on the BSE.
The scrip opened at Rs. 562.00 and has touched a high and low of Rs. 566.00 and Rs. 558.00 respectively. So far 13,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 631.90 on 10-Sep-2012 and a 52 week low of Rs. 409.50 on 14-Dec-2011.
Last one week high and low of the scrip stood at Rs. 579.90 and Rs. 558.00 respectively. The current market cap of the company is Rs. 25,203.00 crore.
The promoters holding in the company stood at 46.89% while Institutions and Non-Institutions held 43.37% and 9.75% respectively.
The company has reported a rise of 20.07% in its net profit at Rs 321.94 crore for the quarter ended September 30, 2012 as compared to Rs 268.12 crore for the same quarter in the previous year. Total income from operation has increased by 24.79% at Rs 1756.70 crore for quarter under review as compared to Rs 1407.73 crore for the quarter ended September 30, 2011.
On consolidated basis, the company has posted a rise of 8.84% in its net profit after tax and minority interest at Rs 290.46 crore for the quarter ended September 30, 2012 as compared to Rs 266.86 crore for the same quarter in the previous year. Total income from operation has increased by 29.93% at Rs 2305.00 crore for quarter under review as compared to Rs 1774.10 crore for the quarter ended September 30, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |